Ritucad 500 mg Injection
521,78$
139,96$
Ritucad 500 mg injection is an advanced monoclonal antibody therapy designed to target and modulate immune responses, making it a vital option for patients battling specific cancers, particularly non-Hodgkin's lymphoma and chronic lymphocytic leukemia. By binding to certain proteins on the surface of cancer cells, Ritucad helps the immune system identify and destroy these malignant cells more effectively. This innovative treatment is not only crucial for cancer management but also plays a role in addressing various immune-related disorders. Patients should be aware of potential side effects, which may include infusion reactions and increased susceptibility to infections, necessitating close monitoring during treatment. As with any medication, it's essential to discuss your full medical history and any existing conditions with your healthcare provider before starting Ritucad. This injection is typically administered under professional supervision to ensure optimal safety and efficacy. With its targeted action, Ritucad offers hope for improved outcomes in the management of complex immunological and oncological conditions.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Ritucad 500 mg injection is primarily used in the treatment of non-Hodgkin lymphoma (NHL). This condition is characterized by the uncontrolled growth of lymphatic cells, leading to various symptoms. The injection helps to target and destroy these malignant cells, effectively managing the disease. Patients receiving Ritucad 500 mg injection may experience improved outcomes and prolonged remission periods.
• Another significant use of Ritucad 500 mg injection is in the management of rheumatoid arthritis. This autoimmune disorder causes chronic inflammation in the joints, leading to pain and disability. Ritucad 500 mg injection works by modulating the immune response, reducing inflammation and preventing joint damage. Many patients find relief from symptoms and improved functionality after treatment with Ritucad 500 mg injection.
• Ritucad 500 mg injection is also indicated for patients with chronic lymphocytic leukaemia (CLL). CLL is a type of blood cancer that affects the bone marrow and blood, leading to the accumulation of abnormal lymphocytes. The injection aids in eliminating these abnormal cells, which can enhance the quality of life for individuals with CLL. By using Ritucad 500 mg injection, healthcare providers aim to control the disease and improve overall patient outcomes.
• Additionally, Ritucad 500 mg injection is utilized in treating conditions such as granulomatosis with polyangiitis and microscopic polyangiitis. These are rare autoimmune diseases that cause inflammation of blood vessels and can affect multiple organ systems. Ritucad 500 mg injection helps to reduce the immune system's inappropriate response, alleviating symptoms and preventing further complications. Patients may benefit from this targeted therapy to manage their conditions effectively.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Ritucad 500 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician. Rheumatoid arthritis: Ritucad 500 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician. Blood cancer (Chronic lymphocytic leukaemia): Leukaemia, also known as blood cancer, is a malignant neoplasm of the haematopoietic tissues that impairs the body's ability to combat infection. Ritucad 500 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukaemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Ritucad 500 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA. Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Ritucad 500 Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Ritucad 500 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Ritucad 500 mg Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Ritucad 500 mg. Please consult your doctor.
• Kidney: Ritucad 500 Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Ritucad 500 mg Injection is likely to be safe to use while breast-feeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Ritucad 500 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Ritucad 500 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Ritucad 500 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.